Source link : https://www.newshealth.biz/health-news/car-t-cell-therapy-safe-in-those-with-autoimmune-disease/
TOPLINE: Patients with and without preexisting autoimmune or inflammatory disease show similar safety and cancer outcomes after chimeric antigen receptor (CAR) T-cell therapy for cancer. METHODOLOGY: Researchers conducted a retrospective cohort study (2017-2023) at the Dana-Farber Cancer Institute, Boston, to investigate safety, cancer progression, and autoimmune or inflammatory disease activity in patients with and without […]
Author : News Health
Publish date : 2025-02-12 08:48:00
Copyright for syndicated content belongs to the linked Source.